{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:30:09Z","timestamp":1786368609980,"version":"build-2736575974"},"reference-count":236,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Major Science and Technology Project in the Autonomous Region","award":["2023A02010-3"],"award-info":[{"award-number":["2023A02010-3"]}]},{"name":"Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences","award":["CI2026A04914"],"award-info":[{"award-number":["CI2026A04914"]}]},{"name":"National Key Research and Development Program of China","award":["2023YFF0724803"],"award-info":[{"award-number":["2023YFF0724803"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82074103"],"award-info":[{"award-number":["82074103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"award":["82074103"],"award-info":[{"award-number":["82074103"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Fundamental Research Funds for the Central public welfare research institutes","award":["ZXKT25004"],"award-info":[{"award-number":["ZXKT25004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Irinotecan is a first-line medication for metastatic colorectal cancer. It is known that irinotecan-induced delayed diarrhea is closely related to metabolic processes in the human body. In particular, the synergies of multiple metabolic enzymes\/transporters mediate the transport\/regeneration of intestinal SN38. This efficient metabolite derived from irinotecan not only exerts robust cytotoxic effects, but also extends contact duration with the intestinal wall during enterohepatic circulation. These factors further affect the intestinal microenvironment, including intestinal flora disorder, intestinal immune dysregulation, and intestinal barrier impairment, which ultimately causes the occurrence of delayed diarrhea. At present, dose adjustment of irinotecan and combining drugs are common measures for clinical use. However, these regimens have shown limited therapeutic efficacy and face the risk of chemotherapy failure. Numerous studies have shown that herbal medicines and derived phytochemicals may also be promising complementary treatments. The characteristics of multi-target regulation of herbs are very suitable for the intervention strategy of complex diseases with multiple pathogenic links. This review focuses on the development of irinotecan-induced delayed diarrhea. We generalized the complex pathogenesis in detail and summarized relevant potential drugs and clinical agents. Special attention was paid to the feasibility of traditional Chinese medicine treatment. This will help expand medication regimens for irinotecan-related diarrhea and provide a reference for the development of precision drugs.<\/jats:p>","DOI":"10.3390\/ph19081192","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:01:46Z","timestamp":1785344506000},"page":"1192","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Comprehensive Review on Irinotecan-Induced Delayed Diarrhea: From Mechanisms to Therapeutic Options"],"prefix":"10.3390","volume":"19","author":[{"given":"Yanli","family":"Wang","sequence":"first","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-879X","authenticated-orcid":false,"given":"Qin","family":"Hu","sequence":"additional","affiliation":[{"name":"College of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Dang","sequence":"additional","affiliation":[{"name":"China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000528282","article-title":"Relationship between Chemotherapy-Induced Diarrhea and Intestinal Microbiome Composition","volume":"104","author":"Kawasaki","year":"2023","journal-title":"Digestion"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Dahlgren, D., Sjoblom, M., Hellstrom, P.M., and Lennernas, H. (2021). Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.681417"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"115787","DOI":"10.1016\/j.bcp.2023.115787","article-title":"Chemotherapy-induced gastrointestinal toxicity: Pathogenesis and current management","volume":"216","author":"He","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Cinausero, M., Aprile, G., Ermacora, P., Basile, D., Vitale, M.G., Fanotto, V., Parisi, G., Calvetti, L., and Sonis, S.T. (2017). New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00354"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tang, L., Li, X., Wan, L., Xiao, Y., Zeng, X., and Ding, H. (2019). Herbal Medicines for Irinotecan-Induced Diarrhea. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00182"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40262-018-0644-7","article-title":"Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics","volume":"57","author":"Goey","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Yue, B., Gao, R., Wang, Z., and Dou, W. (2021). Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.710945"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.explore.2023.08.003","article-title":"Chinese herbal medicine for irinotecan-induced diarrhea: A systematic review and meta-analysis","volume":"20","author":"Lin","year":"2024","journal-title":"Explore"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"176614","DOI":"10.1016\/j.ejphar.2024.176614","article-title":"Mechanisms and emerging strategies for irinotecan-induced diarrhea","volume":"974","author":"Xu","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yang, X., Chen, J., Wang, Y., Wu, Y., and Zhang, J. (2025). Managing Irinotecan-Induced Diarrhea: A Comprehensive Review of Therapeutic Interventions in Cancer Treatment. Pharmaceuticals, 18.","DOI":"10.3390\/ph18030359"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"382","DOI":"10.21037\/tcr.2019.11.39","article-title":"A fatal myelosuppression, diarrhea and neurotoxicity induced by combination of irinotecan and tegafur-gimeracil-oteracil potassium in the treatment of colon cancer: A case report","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e231544","DOI":"10.1136\/bcr-2019-231544","article-title":"Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonide","volume":"12","author":"Shumar","year":"2019","journal-title":"BMJ Case Rep."},{"key":"ref_14","first-page":"258","article-title":"Control of irinotecan-induced diarrhea by octreotide after loperamide failure","volume":"9","author":"Barbounis","year":"2001","journal-title":"Support. Care Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Wang, B., Zhang, Z., Chen, K., Du, Z., Zhang, T., and Xie, P. (2025). Loperamide poisoning resulting in death: A case report and literature review. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1597869"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00228-024-03767-6","article-title":"Evaluating the impact of loperamide on irinotecan-induced adverse events: A disproportionality analysis of data from the World Health Organization pharmacovigilance database (VigiBase)","volume":"81","author":"Akagi","year":"2025","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jacc.2023.06.054","article-title":"Loperamide-Associated Ventricular Arrhythmias","volume":"82","author":"Font","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.annemergmed.2017.04.008","article-title":"Clinical Review: Loperamide Toxicity","volume":"70","author":"Wu","year":"2017","journal-title":"Ann. Emerg. Med."},{"key":"ref_19","first-page":"1378","article-title":"Loperamide Cardiac Toxicity: Pathophysiology, Presentation, and Management","volume":"38","author":"Wu","year":"2022","journal-title":"Can. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10735-025-10367-w","article-title":"Restore intestinal steady-state: New advances in the clinical management of chemotherapy-associated diarrhea and constipation","volume":"56","author":"Chen","year":"2025","journal-title":"J. Mol. Histol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"McQuade, R.M., Stojanovska, V., Abalo, R., Bornstein, J.C., and Nurgali, K. (2016). Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00414"},{"key":"ref_22","first-page":"e68246","article-title":"Octreotide Causing Hyperkalemia: A Case Report and Review of the Literature","volume":"16","author":"Sasidharan","year":"2024","journal-title":"Cureus"},{"key":"ref_23","first-page":"2392","article-title":"Modern Pharmacological Mechanisms of Traditional Chinese Medicine in the Prevention and Treatment of Irinotecan-Induced Delayed Diarrhea","volume":"25","author":"Yan","year":"2016","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"87202","DOI":"10.5493\/wjem.v14.i1.87202","article-title":"Emerging significance of butyrylcholinesterase","volume":"14","author":"Sridhar","year":"2024","journal-title":"World J. Exp. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biochi.2022.09.008","article-title":"Novel activity of human BChE: Lipid hydrolysis","volume":"204","author":"Gok","year":"2023","journal-title":"Biochimie"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.eng.2019.01.015","article-title":"Quality Markers of Traditional Chinese Medicine: Concept, Progress, and Perspective","volume":"5","author":"Li","year":"2019","journal-title":"Engineering"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"106625","DOI":"10.1016\/j.bioorg.2023.106625","article-title":"Design, synthesis, and biological evaluation studies of novel carboxylesterase 2 inhibitors for the treatment of irinotecan-induced delayed diarrhea","volume":"138","author":"Yang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1389200219666180330124050","article-title":"Potential Pharmacokinetic Herb-Drug Interactions: Have we Overlooked the Importance of Human Carboxylesterases 1 and 2?","volume":"20","author":"Xu","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"141069","DOI":"10.1016\/j.bbapap.2025.141069","article-title":"Exploring human carboxylesterases 1 and 2 selectivity of two families of substrates at an atomistic level","volume":"1873","author":"Ribone","year":"2025","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/17425255.2024.2348491","article-title":"Regulation of carboxylesterases and its impact on pharmacokinetics and pharmacodynamics: An up-to-date review","volume":"20","author":"Liu","year":"2024","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.apsb.2018.05.005","article-title":"Human carboxylesterases: A comprehensive review","volume":"8","author":"Wang","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1124\/dmd.121.000476","article-title":"Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation","volume":"49","author":"Parvez","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"115742","DOI":"10.1016\/j.bcp.2023.115742","article-title":"Discovery of novel carboxylesterase 2 inhibitors for the treatment of delayed diarrhea and ulcerative colitis","volume":"215","author":"Cao","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.apsb.2022.10.017","article-title":"Carboxylesterase 1 family knockout alters drug disposition and lipid metabolism","volume":"13","author":"Gan","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2174\/1389200224666221212143904","article-title":"Covalent CES2 Inhibitors Protect against Reduced Formation of Intestinal Organoids by the Anticancer Drug Irinotecan","volume":"23","author":"Eades","year":"2022","journal-title":"Curr. Drug Metab."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"120743","DOI":"10.1016\/j.lfs.2022.120743","article-title":"Inhibition of Radix Scutellariae flavones on carboxylesterase mediated activations of prodrugs","volume":"305","author":"Zhang","year":"2022","journal-title":"Life Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104367","DOI":"10.1016\/j.bioorg.2020.104367","article-title":"Discovery of natural alkaloids as potent and selective inhibitors against human carboxylesterase 2","volume":"105","author":"Zhao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/1078-0432.CCR-09-1526","article-title":"A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan","volume":"16","author":"Mathijssen","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100746","DOI":"10.1016\/j.esmoop.2022.100746","article-title":"The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan","volume":"8","author":"Su","year":"2023","journal-title":"ESMO Open"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0254-6272(17)30024-9","article-title":"Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms","volume":"37","author":"Deng","year":"2017","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"110248","DOI":"10.1016\/j.cbi.2022.110248","article-title":"Inhibition of UGT1A1*1 and UGT1A1*6 catalyzed glucuronidation of SN-38 by silybins","volume":"368","author":"Li","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4161\/cbt.7.12.6940","article-title":"Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats","volume":"7","author":"Stringer","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/BF02975166","article-title":"Intestinal bacterial beta-glucuronidase activity of patients with colon cancer","volume":"24","author":"Kim","year":"2001","journal-title":"Arch. Pharm. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.phrs.2018.10.029","article-title":"Pharmacological inhibition of bacterial beta-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo","volume":"139","author":"Cheng","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"114566","DOI":"10.1016\/j.bcp.2021.114566","article-title":"Human gut bacterial beta-glucuronidase inhibition: An emerging approach to manage medication therapy","volume":"190","author":"Wang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"106115","DOI":"10.1016\/j.phrs.2022.106115","article-title":"Inhibition of gut microbial beta-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis","volume":"177","author":"Cheng","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00280-010-1310-4","article-title":"Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of beta-glucuronidase activity in intestinal lumen","volume":"67","author":"Kurita","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_48","first-page":"1136","article-title":"Modulation of irinotecan-induced diarrhea by cotreatment with neomycin in cancer patients","volume":"7","author":"Kehrer","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1200\/JCO.2005.03.2847","article-title":"Cefixime allows greater dose escalation of oral irinotecan: A phase I study in pediatric patients with refractory solid tumors","volume":"24","author":"Furman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.fct.2017.03.042","article-title":"Structure-activity relationships of flavonoids as natural inhibitors against E. coli beta-glucuronidase","volume":"109","author":"Weng","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Yue, B., Gao, R., Lv, C., Yu, Z., Wang, H., Geng, X., Wang, Z., and Dou, W. (2021). Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial beta-glucuronidase. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.774560"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"155040","DOI":"10.1016\/j.phymed.2023.155040","article-title":"Insight into the mechanism of Xiao-Chai-Hu-Tang alleviates irinotecan-induced diarrhea based on regulating the gut microbiota and inhibiting Gut beta-GUS","volume":"120","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1038\/s41598-023-33731-w","article-title":"Green tea extract prevents CPT-11-induced diarrhea by regulating the gut microbiota","volume":"13","author":"Kon","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7350251","DOI":"10.1155\/2017\/7350251","article-title":"Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats","volume":"2017","author":"Deng","year":"2017","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_55","first-page":"569","article-title":"Effect of Dabupi decoction on irinotecan-induced delayed diarrhea in mice","volume":"45","author":"Yue","year":"2023","journal-title":"Chin. Tradit. Pat. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pharmthera.2018.10.007","article-title":"Organic Anion Transporting Polypeptide (OATP) transporter expression, localization and function in the human intestine","volume":"195","author":"Oswald","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/bjc.2015.5","article-title":"OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy","volume":"112","author":"Teft","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1535-7163.MCT-13-0541","article-title":"OATP1A\/1B transporters affect irinotecan and SN-38 pharmacokinetics and carboxylesterase expression in knockout and humanized transgenic mice","volume":"13","author":"Iusuf","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"ref_59","first-page":"1403","article-title":"Research progress on the correlation between genetic polymorphisms and irinotecan adverse reactions and chemotherapy efficacy","volume":"31","author":"Jia","year":"2020","journal-title":"China Pharm."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.115.066712","article-title":"Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride","volume":"44","author":"Fujita","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"ref_61","unstructured":"Zhu, C.R. (2016). Effects and Mechanisms of Capsaicin on the In Vivo Disposition of Irinotecan in Rats Based on Enzymes and Transporters, Huazhong University of Science and Technology. (In Chinese)."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"114171","DOI":"10.1016\/j.fct.2023.114171","article-title":"Role of MRPs transporters in pharmacokinetics and intestinal toxicity of irinotecan","volume":"182","author":"Du","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ejps.2008.12.005","article-title":"Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats","volume":"36","author":"Bansal","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1023\/A:1023847521767","article-title":"Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats","volume":"20","author":"Arimori","year":"2003","journal-title":"Pharm. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/jpet.106.103606","article-title":"A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor","volume":"319","author":"Yang","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1023\/A:1020358910490","article-title":"Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in rats","volume":"19","author":"Horikawa","year":"2002","journal-title":"Pharm. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.lfs.2008.06.007","article-title":"Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein","volume":"83","author":"Bansal","year":"2008","journal-title":"Life Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/bdd.2024","article-title":"Effect of hesperidin on the pharmacokinetics of CPT-11 and its active metabolite SN-38 by regulating hepatic Mrp2 in rats","volume":"37","author":"Wang","year":"2016","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.2042-7158.2012.01592.x","article-title":"Effect of genistein, a natural soy isoflavone, on the pharmacokinetics and intestinal toxicity of irinotecan hydrochloride in rats","volume":"65","author":"Yokooji","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Guan, H.Y., Li, P.F., Wang, X.M., Yue, J.J., He, Y., Luo, X.M., Su, M.F., Liao, S.G., and Shi, Y. (2017). Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00769"},{"key":"ref_71","unstructured":"Sun, R.J. (2018). The Mechanism of Xiao Chai Hu Tang and Its Components Reduced Irinotecan (CPT-11) Induced Diarrhea, Guangzhou University of Chinese Medicine. (In Chinese)."},{"key":"ref_72","first-page":"890","article-title":"Cancer chemotherapy-induced diarrhoea and constipation: Mechanisms of damage and prevention strategies","volume":"14","author":"Gibson","year":"2006","journal-title":"Support. Care Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"103751","DOI":"10.1016\/j.ebiom.2021.103751","article-title":"MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis","volume":"74","author":"Yao","year":"2021","journal-title":"eBioMedicine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"103717","DOI":"10.1016\/j.autrev.2024.103717","article-title":"Intestinal mucus barrier: A potential therapeutic target for IBD","volume":"24","author":"Qiao","year":"2025","journal-title":"Autoimmun. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"123862","DOI":"10.1016\/j.ijbiomac.2023.123862","article-title":"Orchestration of MUC2\u2014The key regulatory target of gut barrier and homeostasis: A review","volume":"236","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1440-1746.2003.03136.x","article-title":"Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer","volume":"18","author":"Gibson","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00280-008-0855-y","article-title":"Irinotecan-induced mucositis is associated with changes in intestinal mucins","volume":"64","author":"Stringer","year":"2009","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2613.2009.00671.x","article-title":"Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile","volume":"90","author":"Stringer","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12253-019-00644-x","article-title":"Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model","volume":"26","author":"Thorpe","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Di Tommaso, N., Gasbarrini, A., and Ponziani, F.R. (2021). Intestinal Barrier in Human Health and Disease. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph182312836"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"153117","DOI":"10.1016\/j.tox.2022.153117","article-title":"Extracellular histones cause intestinal epithelium injury and disrupt its barrier function in vitro and in vivo","volume":"469","author":"Chen","year":"2022","journal-title":"Toxicology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e2411052","DOI":"10.1002\/advs.202411052","article-title":"beta-Glucuronidase-Expressing Lactobacillus reuteri Triggers Irinotecan Enterotoxicity Through Depleting the Regenerative Epithelial Stem\/Progenitor Pool","volume":"12","author":"Yue","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1016\/j.apsb.2024.09.018","article-title":"Targeted inhibition of Gus-expressing Enterococcus faecalis to promote intestinal stem cell and epithelial renovation contributes to the relief of irinotecan chemotoxicity by dehydrodiisoeugenol","volume":"14","author":"Gao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"116529","DOI":"10.1016\/j.lfs.2019.06.004","article-title":"The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice","volume":"231","author":"Wang","year":"2019","journal-title":"Life Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"115752","DOI":"10.1016\/j.bcp.2023.115752","article-title":"Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice","volume":"216","author":"Xiao","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e13357","DOI":"10.1111\/asj.13357","article-title":"Regulation of the intestinal barrier by nutrients: The role of tight junctions","volume":"91","author":"Suzuki","year":"2020","journal-title":"Anim. Sci. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gutjnl-2018-316906","article-title":"Tight junction proteins in gastrointestinal and liver disease","volume":"68","author":"Zeisel","year":"2019","journal-title":"Gut"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jss.2010.10.003","article-title":"Irinotecan injures tight junction and causes bacterial translocation in rat","volume":"173","author":"Nakao","year":"2012","journal-title":"J. Surg. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4161\/cbt.27222","article-title":"Irinotecan disrupts tight junction proteins within the gut: Implications for chemotherapy-induced gut toxicity","volume":"15","author":"Wardill","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Li, Y., Xia, S., Jiang, X., Feng, C., Gong, S., Ma, J., Fang, Z., Yin, J., and Yin, Y. (2021). Gut Microbiota and Diarrhea: An Updated Review. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.625210"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/1078-0432.CCR-05-0750","article-title":"Intestinal microflora and digestive toxicity of irinotecan in mice","volume":"12","author":"Brandi","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Mahdy, M.S., Azmy, A.F., Dishisha, T., Mohamed, W.R., Ahmed, K.A., Hassan, A., Aidy, S.E., and El-Gendy, A.O. (2023). Irinotecan-gut microbiota interactions and the capability of probiotics to mitigate Irinotecan-associated toxicity. BMC Microbiol., 23.","DOI":"10.1186\/s12866-023-02791-3"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-immunol-090222-102035","article-title":"Microbial Metabolites and Gut Immunology","volume":"42","author":"Takeuchi","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.jcmgh.2021.02.007","article-title":"Regulation of Intestinal Barrier Function by Microbial Metabolites","volume":"11","author":"Ghosh","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","article-title":"Microbial Regulation of Host Physiology by Short-chain Fatty Acids","volume":"29","author":"Wells","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Parada Venegas, D., De la Fuente, M.K., Landskron, G., Gonzalez, M.J., Quera, R., Dijkstra, G., Harmsen, H.J.M., Faber, K.N., and Hermoso, M.A. (2019). Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases. Front. Immunol., 10, Correction in Front. Immunol. 2019, 10, 1486. https:\/\/doi.org\/10.3389\/fimmu.2019.01486.","DOI":"10.3389\/fimmu.2019.01486"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Lin, X.B., Farhangfar, A., Valcheva, R., Sawyer, M.B., Dieleman, L., Schieber, A., Ganzle, M.G., and Baracos, V. (2014). The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0083644"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"10927","DOI":"10.1021\/acsomega.8b00064","article-title":"Characterization of the Functional Changes in Mouse Gut Microbiome Associated with Increased Akkermansia muciniphila Population Modulated by Dietary Black Raspberries","volume":"3","author":"Tu","year":"2018","journal-title":"ACS Omega"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/138920009787048419","article-title":"Chemotherapy-induced modifications to gastrointestinal microflora: Evidence and implications of change","volume":"10","author":"Stringer","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1080\/10408398.2016.1245650","article-title":"Short-chain fatty acids in control of energy metabolism","volume":"58","author":"Hu","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Cui, D.N., Wang, X., Chen, J.Q., Lv, B., Zhang, P., Zhang, W., Zhang, Z.J., and Xu, F.G. (2017). Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00211"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_103","first-page":"4114","article-title":"Research progress on irinotecan induced metabolic dysregulation in microbiotagut-liver axis and Chinese materia medica intervention","volume":"48","author":"Tan","year":"2017","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2024-334699","article-title":"Bacteroides intestinalis mediates the sensitivity to irinotecan toxicity via tryptophan catabolites","volume":"75","author":"Hou","year":"2025","journal-title":"Gut"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"FXR signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejps.2017.03.012","article-title":"Irinotecan-induced bile acid malabsorption is associated with down-regulation of ileal Asbt (Slc10a2) in mice","volume":"102","author":"Shi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2023.02.022","article-title":"The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases","volume":"164","author":"Fogelson","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.taap.2015.12.003","article-title":"Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression","volume":"291","author":"Fang","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"110842","DOI":"10.1016\/j.intimp.2023.110842","article-title":"Gut immune microenvironment and autoimmunity","volume":"124","author":"Wang","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Wong, D.V., Lima-Junior, R.C., Carvalho, C.B., Borges, V.F., Wanderley, C.W., Bem, A.X., Leite, C.A., Teixeira, M.A., Batista, G.L., and Silva, R.L. (2015). The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0139985"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00595-017-1518-6","article-title":"TU-100 exerts a protective effect against bacterial translocation by maintaining the tight junction","volume":"47","author":"Takasu","year":"2017","journal-title":"Surg. Today"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.4049\/jimmunol.1402598","article-title":"Lipopolysaccharide Regulation of Intestinal Tight Junction Permeability Is Mediated by TLR4 Signal Transduction Pathway Activation of FAK and MyD88","volume":"195","author":"Guo","year":"2015","journal-title":"J. Immunol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","article-title":"The gut microbiota is associated with immune cell dynamics in humans","volume":"588","author":"Schluter","year":"2020","journal-title":"Nature"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"110262","DOI":"10.1016\/j.biopha.2020.110262","article-title":"Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice","volume":"128","author":"Wang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"115906","DOI":"10.1016\/j.biopha.2023.115906","article-title":"Irinotecan cause the side effects on development and adult physiology, and induces intestinal damage via innate immune response and oxidative damage in Drosophila","volume":"169","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.taap.2015.09.025","article-title":"CPT-11 activates NLRP3 inflammasome through JNK and NF-kappaB signalings","volume":"289","author":"Li","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1038\/sj.bjc.6605051","article-title":"Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy","volume":"100","author":"Xue","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejps.2018.01.006","article-title":"Role of regulatory T cells in irinotecan-induced intestinal mucositis","volume":"115","author":"Fernandes","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S2468-1253(17)30031-6","article-title":"Resolution of inflammation in inflammatory bowel disease","volume":"2","author":"Rogler","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Marcuzzi, A., Melloni, E., Zauli, G., Romani, A., Secchiero, P., Maximova, N., and Rimondi, E. (2021). Autoinflammatory Diseases and Cytokine Storms-Imbalances of Innate and Adaptative Immunity. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222011241"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.toxicon.2017.10.016","article-title":"Exotoxins and endotoxins: Inducers of inflammatory cytokines","volume":"149","author":"Cavaillon","year":"2018","journal-title":"Toxicon"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"157071","DOI":"10.1016\/j.phymed.2025.157071","article-title":"Brusatol ameliorates irinotecan-induced delayed diarrhea via inhibition of the cGAS-STING pathway and modulation of intestinal flora","volume":"145","author":"Lai","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"146339","DOI":"10.1016\/j.ijbiomac.2025.146339","article-title":"Protective effect of HPS against irinotecan-induced intestinal injury in drosophila and mice via modulation of inflammation, oxidation, and gut microbiota","volume":"321","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cbi.2016.11.009","article-title":"Carvacrol reduces irinotecan-induced intestinal mucositis through inhibition of inflammation and oxidative damage via TRPA1 receptor activation","volume":"260","author":"Alvarenga","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"ref_128","first-page":"90","article-title":"Using the Common Terminology Criteria for Adverse Events (CTCAE\u2014Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies","volume":"112","author":"Santana","year":"2021","journal-title":"Actas Dermosifiliogr. (Engl. Ed.)"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"iv126","DOI":"10.1093\/annonc\/mdy145","article-title":"Diarrhoea in adult cancer patients: ESMO Clinical Practice Guidelines","volume":"29","author":"Bossi","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpainsymman.2011.06.001","article-title":"Loperamide","volume":"42","author":"Regnard","year":"2011","journal-title":"J. Pain Symptom Manag."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"107852","DOI":"10.1016\/j.bioorg.2024.107852","article-title":"Discovery of the FXR\/CES2 dual modulator LE-77 for the treatment of irinotecan-induced delayed diarrhea","volume":"153","author":"Cao","year":"2024","journal-title":"Bioorganic Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2014.03.007","article-title":"IL-1Ra selectively protects intestinal crypt epithelial cells, but not tumor cells, from chemotoxicity via p53-mediated upregulation of p21(WAF1) and p27(KIP1.)","volume":"82","author":"Wang","year":"2014","journal-title":"Pharmacol. Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00280-006-0273-y","article-title":"Adsorption of irinotecan onto oral adsorbent AST-120 (Kremezin) for preventing delayed diarrhea","volume":"59","author":"Hidaka","year":"2007","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2004.11.125","article-title":"Phase II study of activated charcoal to prevent irinotecan-induced diarrhea","volume":"22","author":"Michael","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00432-004-0557-8","article-title":"Saccharic acid 1.4-lactone protects against CPT-11-induced mucosa damage in rats","volume":"130","author":"Fittkau","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1158\/1078-0432.CCR-14-0395","article-title":"Old drug new use--amoxapine and its metabolites as potent bacterial beta-glucuronidase inhibitors for alleviating cancer drug toxicity","volume":"20","author":"Kong","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/138920006776873517","article-title":"Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide","volume":"7","author":"Yang","year":"2006","journal-title":"Curr. Drug Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00280-007-0534-4","article-title":"Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: Effect of pentoxifylline and thalidomide","volume":"61","author":"Melo","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1158\/1078-0432.CCR-03-0496","article-title":"Oral RDP58 allows CPT-11 dose intensification for enhanced tumor response by decreasing gastrointestinal toxicity","volume":"10","author":"Zhao","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_140","first-page":"5778","article-title":"Cyclooxygenase-2 inhibition with celecoxib enhances antitumor efficacy and reduces diarrhea side effect of CPT-11","volume":"62","author":"Trifan","year":"2002","journal-title":"Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ejphar.2018.07.044","article-title":"Darunavir alleviates irinotecan-induced intestinal toxicity in Vivo","volume":"834","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-022-04463-x","article-title":"Effects of a novel toll-like receptor 4 antagonist IAXO-102 in a murine model of chemotherapy-induced gastrointestinal toxicity","volume":"90","author":"Tam","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2429029","DOI":"10.1080\/07853890.2024.2429029","article-title":"Rifaximin alleviates irinotecan-induced diarrhea in mice model","volume":"56","author":"Huang","year":"2024","journal-title":"Ann. Med."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Zhang, R., Zhu, X., Bai, H., and Ning, K. (2019). Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00123"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Zhang, W., Huai, Y., Miao, Z., Qian, A., and Wang, Y. (2019). Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00743"},{"key":"ref_146","unstructured":"Liu, P.K. (2019). Study of Huangqin Decoction on Alleviating Intestinal Toxicity of Irinotecan by Protecting Intestinal Mucosal Barrier. [Master\u2019s Thesis, Dalian Medical University]. (In Chinese)."},{"key":"ref_147","first-page":"163","article-title":"Experimental Study on Preventive Effect of Huangqin Tang on Irinotecan Induced Delayed Diarrhea","volume":"19","author":"Wu","year":"2013","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Wang, X., Cui, D.N., Dai, X.M., Wang, J., Zhang, W., Zhang, Z.J., and Xu, F.G. (2017). HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00156"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"45ra59","DOI":"10.1126\/scitranslmed.3001270","article-title":"The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity","volume":"2","author":"Lam","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"119790","DOI":"10.1016\/j.jep.2025.119790","article-title":"Huangqin decoction alleviated irinotecan-induced diarrhea by inhibiting endoplasmic reticulum stress through activating AMPK\/mTOR-mediated autophagy","volume":"347","author":"He","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"120135","DOI":"10.1016\/j.jep.2025.120135","article-title":"Huangqin decoction alleviates chemotherapy-induced intestinal injury by inhibiting ferroptosis via modulation of P53\/SLC7A11\/GPX4 pathway","volume":"351","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_152","first-page":"1236","article-title":"Effect of Shengjiang Xiexin Decoction on the Repair of Damaged Rat Intestinal Mucosa after Irinotecan Chemotherapy","volume":"35","author":"Wang","year":"2015","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"key":"ref_153","unstructured":"Gao, Y. (2021). Study on the Mechanism of Shen-Jiang-Xiexin Decoction in Preventing Irinotecan-Induced Delayed Diarrhea. [Master\u2019s Thesis, Beijing University of Chinese Medicine]. (In Chinese)."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"114197","DOI":"10.1016\/j.jep.2021.114197","article-title":"Exploration of the potential mechanism of Banxia Xiexin Decoction for the effects on TNBS-induced ulcerative colitis rats with the assistance of network pharmacology analysis","volume":"277","author":"Wang","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"ref_155","first-page":"620","article-title":"Preventive effects of Shengjiang Xiexin Decoction against irinotecan-induced toxicity in CT26 tumorbearing mice","volume":"23","author":"Deng","year":"2007","journal-title":"Chin. J. Immunol."},{"key":"ref_156","first-page":"475","article-title":"Shengjiang Xiexin Decoction treats irinotecan-induced delayed diarrhea in colorectal carcinoma mice","volume":"39","author":"Peng","year":"2017","journal-title":"Chin. Tradit. Pat. Med."},{"key":"ref_157","unstructured":"Hu, P. (2018). Effect of Xiaochaihu Decoction on Irinotecan Metabolism and Intestinal Protection, Hubei University of Science and Technology. (In Chinese)."},{"key":"ref_158","first-page":"1762","article-title":"Preventive and Treatment Effects of Xiaochaihu Decoction on Irinotecan-induced Bloodystool in Model Mice with Delayed Diarrhea","volume":"28","author":"Zhou","year":"2017","journal-title":"China Pharm."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2174\/1568009618666181029153255","article-title":"Xiao-Chai-Hu-Tang (XCHT) Intervening Irinotecan\u2019s Disposition: The Potential of XCHT in Alleviating Irinotecan-Induced Diarrhea","volume":"19","author":"Sun","year":"2019","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_160","unstructured":"Song, W.J. (2018). Xiao Chai Hu Tang Attenuated the SN38 Induced Diarrhea via Inhibition of its Related Efflux Transporter, Guangzhou University of Chinese Medicine. (In Chinese)."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1002\/iid3.1208","article-title":"Banxia Xiexin decoction combined with 5-ASA protects against CPT-11-induced intestinal dysfunction in rats via inhibiting TLR4\/NF-kappaB signaling pathway","volume":"12","author":"Zou","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.biopha.2018.11.095","article-title":"Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice","volume":"109","author":"Wu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13020-023-00747-3","article-title":"Gegen Qinlian standard decoction alleviated irinotecan-induced diarrhea via PI3K\/AKT\/NF-kappaB axis by network pharmacology prediction and experimental validation combination","volume":"18","author":"Chen","year":"2023","journal-title":"Chin. Med."},{"key":"ref_164","first-page":"1497","article-title":"Effects of Gancao Xiexin Decoction on irinotecan-induced diarrhea mice based on gut microbiota","volume":"46","author":"Nie","year":"2023","journal-title":"Drug Eval. Res."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Chan, Y.T., Cheung, F., Zhang, C., Fu, B., Tan, H.Y., Norimoto, H., Wang, N., and Feng, Y. (2020). Ancient Chinese Medicine Herbal Formula Huanglian Jiedu Decoction as a Neoadjuvant Treatment of Chemotherapy by Improving Diarrhea and Tumor Response. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00252"},{"key":"ref_166","first-page":"1169","article-title":"Effects of decoction for regulating spleen and calming intestine on intestinal flora in irinotecan delayed diarrhea in mice","volume":"33","author":"Sun","year":"2024","journal-title":"Mod. J. Integr. Tradit. Chin. West. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00203-023-03526-8","article-title":"Pogostemon cablin (Blanco) Benth granule revealed a positive effect on improving intestinal barrier function and fecal microbiota in mice with irinotecan-induced intestinal mucositis","volume":"205","author":"Li","year":"2023","journal-title":"Arch. Microbiol."},{"key":"ref_168","first-page":"64","article-title":"Role of Fuzi Lizhong pill anti-inflammatory and antidiarrheal effects on rats with irinotecan-induced diarrheal based on NLRP-3 inflammasomes","volume":"45","author":"Luo","year":"2024","journal-title":"J. Yangzhou Univ. (Agric. Life Sci. Ed.)"},{"key":"ref_169","unstructured":"Xia, T. (2019). The Protective Effect of WCA Pills and Its Main Active Constitution Magnolol on Irinotecan and Other Chemotherapeutic Agents Induced Intestinal Toxicity. [Master\u2019s Thesis, Tianjin University]. (In Chinese)."},{"key":"ref_170","first-page":"1294","article-title":"Effect of Sishen Pill on Delayed Diarrhea-Induced by Irinotecan in Mice","volume":"44","author":"Ji","year":"2017","journal-title":"Liaoning J. Tradit. Chin. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.21037\/tcr-22-2145","article-title":"Effects of Shu Bu Wenshen Guchang recipe on intestinal injury and the TLR4\/NF-kappaB signaling pathways in mice with irinotecan-induced delayed-type diarrhea","volume":"11","author":"Zhang","year":"2022","journal-title":"Transl. Cancer Res."},{"key":"ref_172","unstructured":"Wang, J. (2023). Study on the Mechanism of Hezhongfang Interfering with Delayed Diarrhea of Irinotecan in Tumor-bearing Mice. [Master\u2019s Thesis, Chengdu University of TCM]. (In Chinese)."},{"key":"ref_173","first-page":"342","article-title":"Protective effects of Tangcaopian on irinotecan induced toxicity in mice","volume":"25","author":"Liang","year":"2019","journal-title":"Chin. J. AIDS STD"},{"key":"ref_174","first-page":"1942","article-title":"Effect of Shenlingbaizhu powder on delayed diarrhea in rats after irinotecan chemotherapy","volume":"13","author":"Ding","year":"2011","journal-title":"Chin. J. Med. Guide"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"13745","DOI":"10.2147\/JIR.S536184","article-title":"Mechanistic Exploration of Shenling Baizhu Powder in Treating Irinotecan-Associated Diarrhea: A Study Based on Network Pharmacology and Experimental Validation","volume":"18","author":"Liu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_176","unstructured":"Chen, Q.R. (2018). Clinical Study of Jianpi-Yiqi Decoction in the Prevention and Treatment of Delayed Diarrhea Caused by Irinotecan. [Master\u2019s Thesis, Beijing University of TCM]. (In Chinese)."},{"key":"ref_177","unstructured":"Wang, L.Y. (2022). Clinical Effect Observation of Gu Ben Yi Chang Table on Irinotecan-Induced Diarrhea after Chemotherapy. [Master\u2019s Thesis, Shandong University of Traditional Chinese Medicine]. (In Chinese)."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.2147\/DDDT.S517973","article-title":"Therapeutic Effect of Brucea Javanica Oil Emulsion in Mice with Irinotecan-Induced Delayed Diarrhea","volume":"19","author":"Lai","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_179","first-page":"16","article-title":"The mechanism of trichloromethane extract of Gegenqinlian decoction in alleviating irinotecan-induced intestinal toxicity","volume":"27","author":"Wu","year":"2021","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.18632\/aging.204695","article-title":"Ling Zhi-8, a fungal immunomodulatory protein in Ganoderma lucidum, alleviates CPT-11-induced intestinal injury via restoring claudin-1 expression","volume":"15","author":"Li","year":"2023","journal-title":"Aging"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Yue, S.J., Qin, Y.F., Kang, A., Tao, H.J., Zhou, G.S., Chen, Y.Y., Jiang, J.Q., Tang, Y.P., and Duan, J.A. (2021). Total Flavonoids of Glycyrrhiza uralensis Alleviates Irinotecan-Induced Colitis via Modification of Gut Microbiota and Fecal Metabolism. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.628358"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1615\/IntJMedMushr.v8.i4.30","article-title":"Water-Soluble Polysaccharides of Ganoderma lucidum (W.Curt.:Fr.) P. Karst. (Aphyllophoromycetideae) Alleviate the Dose-Limiting Toxicities of Irinotecan (CPT-11)","volume":"8","author":"Hu","year":"2006","journal-title":"Int. J. Med. Mushrooms"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.taap.2006.05.020","article-title":"St. John\u2019s wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis","volume":"216","author":"Hu","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ptr.6202","article-title":"Flavonoid-rich fraction of Bauhinia forficata Link leaves prevents the intestinal toxic effects of irinotecan chemotherapy in IEC-6 cells and in mice","volume":"33","author":"Boeing","year":"2019","journal-title":"Phytother. Res."},{"key":"ref_185","unstructured":"Song, Y.Y. (2020). Study on the Effect and Mechanism of Water Extract of Fructus Mume on Diarrhea Induced by Irinotecan. [Master\u2019s Thesis, Huazhong University of Science and Technology]. (In Chinese)."},{"key":"ref_186","first-page":"1376","article-title":"Protective effect of curcumin against irinotecan-induced intestinal mucosal injury via attenuation of NF-kappaB activation, oxidative stress and endoplasmic reticulum stress","volume":"54","author":"Ouyang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"105888","DOI":"10.1016\/j.tiv.2024.105888","article-title":"Selected phytocannabinoids inhibit SN-38- and cytokine-evoked increases in epithelial permeability and improve intestinal barrier function in vitro","volume":"99","author":"Marsh","year":"2024","journal-title":"Toxicol. In Vitro"},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Shu, X., Xu, R., Xiong, P., Liu, J., Zhou, Z., Shen, T., and Zhang, X. (2024). Exploring the Effects and Potential Mechanisms of Hesperidin for the Treatment of CPT-11-Induced Diarrhea: Network Pharmacology, Molecular Docking, and Experimental Validation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25179309"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/cbdd.14349","article-title":"Baicalein, a component of banxia xiexin decoction, alleviates CPT-11-induced gastrointestinal dysfunction by inhibiting ALOX15-mediated ferroptosis","volume":"102","author":"Pei","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jff.2017.01.051","article-title":"Beneficial effects of anthocyanins from red cabbage (Brassica oleracea L. var. capitata L.) administration to prevent irinotecan-induced mucositis","volume":"32","author":"Tong","year":"2017","journal-title":"J. Funct. Foods"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"109712","DOI":"10.1016\/j.cbi.2021.109712","article-title":"The PPARgamma-dependent effect of flavonoid luteolin against damage induced by the chemotherapeutic irinotecan in human intestinal cells","volume":"351","author":"Boeing","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"155371","DOI":"10.1016\/j.phymed.2024.155371","article-title":"Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4\/MD2 complex formation","volume":"128","author":"Sun","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.apsb.2021.03.043","article-title":"DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS\u2013STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_194","unstructured":"Shu, H. (2017). The Inhibition of Schisandra Chinensis Extract on CES2 and CYP450s, and Its Effect on Relieving Diarrhea Caused by Irinotecan. [Master\u2019s Thesis, Dalian Medical University]. (In Chinese)."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"110205","DOI":"10.1016\/j.intimp.2023.110205","article-title":"Artesunate ameliorates irinotecan-induced intestinal injury by suppressing cellular senescence and significantly enhances anti-tumor activity","volume":"119","author":"Jia","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1021\/acs.jafc.4c09602","article-title":"Supplementary Hesperidin Alleviated CPT-11-Induced Diarrhea by Modulating Gut Microbiota and Inhibiting the IL-17 Signaling Pathway","volume":"73","author":"Zhang","year":"2025","journal-title":"J. Agric. Food Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"7973","DOI":"10.2147\/JIR.S504696","article-title":"Saikosaponin-d Attenuates Irinotecan-Induced Intestinal Toxicity via TAK1\/NF-kappaB Pathway and Enhances Antitumor Efficacy","volume":"18","author":"Zheng","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"117416","DOI":"10.1016\/j.taap.2025.117416","article-title":"Tectorigenin alleviates irinotecan-induced intestinal inflammation by activating the Nrf2\/Keap1 pathway and synergistically enhances the anti-colon cancer efficacy of irinotecan","volume":"502","author":"Ma","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"154737","DOI":"10.1016\/j.phymed.2023.154737","article-title":"Shengjiang Xiexin Decoction ameliorates antibiotic-associated diarrhea by altering the gut microbiota and intestinal metabolic homeostasis","volume":"113","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Lam, W., Ren, Y., Guan, F., Jiang, Z., Cheng, W., Xu, C.H., Liu, S.H., and Cheng, Y.C. (2018). Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906). Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01324"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jep.2015.03.027","article-title":"Banxia xiexin decoction protects against dextran sulfate sodium-induced chronic ulcerative colitis in mice","volume":"166","author":"Chen","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"117990","DOI":"10.1016\/j.jep.2024.117990","article-title":"Banxia Xiexin decoction modulates gut microbiota and gut microbiota metabolism to alleviate DSS-induced ulcerative colitis","volume":"326","author":"Luo","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"ref_203","first-page":"65","article-title":"Exploration into the Medication Rules of Herbal Treatment for Delayed Diarrhea Induced by Irinotecan Based on Association Rules and Cluster Analysis","volume":"38","author":"He","year":"2025","journal-title":"West. J. Tradit. Chin. Med."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.phymed.2009.12.016","article-title":"Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies","volume":"17","author":"Saif","year":"2010","journal-title":"Phytomedicine"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1002\/onco.13582","article-title":"A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma","volume":"26","author":"Changou","year":"2021","journal-title":"Oncologist"},{"key":"ref_206","first-page":"85","article-title":"A phase I study of the chinese herbal medicine PHY906 as a modulator of irinotecan-based chemotherapy in patients with advanced colorectal cancer","volume":"10","author":"Kummar","year":"2011","journal-title":"Clin. Colorectal Cancer"},{"key":"ref_207","first-page":"2264","article-title":"Clinical Study about Huangqin Decoction Preventing Diarrhea after Chemotherapy Including Irinotecan","volume":"40","author":"Ren","year":"2013","journal-title":"Liaoning J. Tradit. Chin. Med."},{"key":"ref_208","first-page":"427","article-title":"Observation on the therapeutic effect of Jiawei Huangqin Tang on the prevention of delayed diarrhea caused by Irinotecan-based chemotherapy at the late stage of colorectal cancer","volume":"34","author":"Yu","year":"2015","journal-title":"Beijing J. Tradit. Chin. Med."},{"key":"ref_209","first-page":"1470","article-title":"Clinical Observation on Banxia Xiexin Decoction in Treating Irinotecan Chemotherapy-Induced Delayed-Onset Diarrhea","volume":"40","author":"Shen","year":"2024","journal-title":"J. Pract. Tradit. Chin. Med."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13020-021-00528-w","article-title":"Effect of Banxia Xiexin Decoction on the Treatment of Delayed Diarrhea Caused by Irinotecan","volume":"19","author":"Liu","year":"2021","journal-title":"Guide China Med."},{"key":"ref_211","unstructured":"Lin, X.L. (2021). Clinical Study on Banxia Xiexin Decoction in Prevention and Treating of Irinotecan Induced Delayed Diarrhea. [Master\u2019s Thesis, Chengdu University of Traditional Chinese Medicine]. (In Chinese)."},{"key":"ref_212","first-page":"2020","article-title":"Clinical Observation of Banxia Xiexin Decoction in Prevention of Tardive Diarrhea Toxicity of Irinotecan","volume":"30","author":"Kong","year":"2012","journal-title":"Chin. Arch. Tradit. Chin. Med."},{"key":"ref_213","first-page":"57","article-title":"A Comparative Study on Prevention of Diarrhea Caused by Irinotecan with Different Dosage Forms of Banxia Xiexin Decoction","volume":"23","author":"Wang","year":"2021","journal-title":"J. Liaoning Univ. Tradit. Chin. Med."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/jcpt.13020","article-title":"A randomized controlled, open-label early phase II trial comparing incidence of FOLFIRI.3-induced diarrhoea between Hangeshashinto and oral alkalization in Japanese patients with colorectal cancer","volume":"44","author":"Yamazaki","year":"2019","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00280-003-0585-0","article-title":"Preventive effect of Kampo medicine (Hangeshashin-to) against irinotecan-induced diarrhea in advanced non-small-cell lung cancer","volume":"51","author":"Mori","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_216","first-page":"1073","article-title":"Role of jia wei banxia xie xin fang in the prevention of tardive diarrheatoxicity of irinotecan","volume":"11","author":"Zhang","year":"2008","journal-title":"Anhui Med. Pharm. J."},{"key":"ref_217","unstructured":"Jiang, S. (2014). Clinical Study on Jiawei Banxia Xiexin Decoction for Preventing Irinotecan-Induced Delayed-Onset Diarrhea, Anhui University of Chinese Medicine. (In Chinese)."},{"key":"ref_218","unstructured":"Zhao, S.Y. (2023). Clinical Study on Shengjiang Xiexin Decoction for Preventing and Treating Irinotecan-Induced Delayed-Onset Diarrhea, Beijing University of Chinese Medicine. (In Chinese)."},{"key":"ref_219","unstructured":"Deng, H.Y. (2007). Study on Shengjiang Xiexin Decoction for Prevention of Irinotecan-Induced Delayed-Onset Diarrhea, Beijing University of Chinese Medicine. (In Chinese)."},{"key":"ref_220","first-page":"22","article-title":"Clinical Study on the Efficacy and Safety of Shenling Baizhu Powder in the Prevention andTreatment of Delayed Diarrhea Caused by Irinotecan","volume":"40","author":"Liu","year":"2022","journal-title":"Zhonghua Yangsheng Baojian"},{"key":"ref_221","unstructured":"Li, Z.Y. (2016). Clinical Observation on Modified Shenling Baizhu Powder for Prevention and Treatment of Irinotecan Chemotherapy-Induced Delayed-Onset Diarrhea. [Master\u2019s Thesis, Chengdu University of Traditional Chinese Medicine]. (In Chinese)."},{"key":"ref_222","unstructured":"Niu, W.P. (2018). Clinical Observation Of Tong Xie Yao Fang In The Prevention Of Tardive Diarrhea Toxicity Of Irinotean. [Master\u2019s Thesis, Qingdao University]. (In Chinese)."},{"key":"ref_223","first-page":"1414","article-title":"Modern research progress on classic formula Huangqin Decoction","volume":"56","author":"Guo","year":"2025","journal-title":"Chin. Tradit. Herb. Drugs"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"154052","DOI":"10.1016\/j.phymed.2022.154052","article-title":"Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier","volume":"100","author":"Li","year":"2022","journal-title":"Phytomedicine"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12032-008-9128-1","article-title":"The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea","volume":"26","author":"Sezer","year":"2009","journal-title":"Med. Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Li, M., Huang, Y., Jin, H., Yuan, D., Huang, K., Wang, J., Tan, B., and Yin, Y. (2022). Vitamin A Ameliorated Irinotecan-Induced Diarrhea in a Piglet Model Involving Enteric Glia Modulation and Immune Cells Infiltration. Nutrients, 14.","DOI":"10.3390\/nu14235120"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"110820","DOI":"10.1016\/j.biopha.2020.110820","article-title":"Anti-tumor activities and mechanisms of Traditional Chinese medicines formulas: A review","volume":"132","author":"Fan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/jn\/138.4.740","article-title":"Bolus oral glutamine protects rats against CPT-11-induced diarrhea and differentially activates cytoprotective mechanisms in host intestine but not tumor","volume":"138","author":"Xue","year":"2008","journal-title":"J. Nutr."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41598-025-30385-8","article-title":"Butyrate prevents chemotherapy-induced gastrointestinal toxicity and microbial dysbiosis","volume":"16","author":"Cheatham","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Yue, F., Zeng, X., Wang, Y., Fang, Y., Yue, M., Zhao, X., Zhu, R., Zeng, Q., Wei, J., and Chen, T. (2024). Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis. BMC Microbiol., 24.","DOI":"10.1186\/s12866-023-03152-w"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"120243","DOI":"10.1016\/j.lfs.2021.120243","article-title":"Bifidobacterium longum subsp. longum 5(1A) attenuates intestinal injury against irinotecan-induced mucositis in mice","volume":"289","author":"Quintanilha","year":"2022","journal-title":"Life Sci."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"120445","DOI":"10.1016\/j.lfs.2022.120445","article-title":"Paraprobiotic Enterococcus faecalis EC-12 prevents the development of irinotecan-induced intestinal mucositis in mice","volume":"296","author":"Nobre","year":"2022","journal-title":"Life Sci."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3920\/BM2018.0096","article-title":"Preventative effects of selenium-enriched Bifidobacterium longum on irinotecan-induced small intestinal mucositis in mice","volume":"10","author":"Qiu","year":"2019","journal-title":"Benef. Microbes"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41538-025-00473-0","article-title":"Improved gut microbiota by selenium-enriched Bifidobacterium longum DD98 alleviates chemotherapy-induced intestinal mucositis via inhibiting the STING pathway","volume":"9","author":"Qiu","year":"2025","journal-title":"npj Sci. Food"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.toxlet.2025.07.356","article-title":"P12-22 Anthocyanin-rich elderberry extract during chemotherapy: Berry good or berry bad?","volume":"411","author":"Ahmed","year":"2025","journal-title":"Toxicol. Lett."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Ni, B., Xue, K., Wang, J., Zhou, J., Wang, L., Wang, X., Liu, T., Ye, N., and Jiang, J. (2024). Integrating Chinese medicine into mainstream cancer therapies: A promising future. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1412370"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:49:06Z","timestamp":1786366146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/8\/1192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":236,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ph19081192"],"URL":"https:\/\/doi.org\/10.3390\/ph19081192","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}